Article
Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade
20 Mar 2024
Abstract excerpt
BACKGROUND: Immune checkpoint blockade (ICB) has revolutionized the treatment of various cancer types. Despite significant preclinical advancements in understanding mechanisms, identifying the molecular basis and predictive biomarkers for clinical ICB responses remains challenging. Recent evidence, both preclinical and clinical, underscores the pivotal role of the extracellular matrix (ECM) in modulating immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
